Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Pre-Open Stock Movers 05/23: VMware Surges on Possible Broadcom Takeover; Retails Stocks Sick Again on Downgrades (more...)

Published 05/23/2022, 09:22 PM
Updated 05/23/2022, 09:22 PM

Pre-Open Stock Movers:

VMware (NYSE:VMW) 20% HIGHER; Broadcom (NASDAQ:AVGO) is in advanced talks to acquire VMware (VMW), according to various media sources.

SIGA Technologies, Inc. (SIGA) 17% HIGHER; continues higher on Monkey Pox play,

Porch Group Inc. (PRCH) 11% HIGHER; JPMorgan (NYSE:JPM) initiates with an Overweight rating and a price target of $8.00.

ImmunoGen , Inc. (Nasdaq: NASDAQ:IMGN) 10% HIGHER; The FDA has accepted and filed the Biologics License Application (BLA) for mirvetuximab soravtansine monotherapy in patients with folate receptor alpha (FR)-high platinum-resistant ovarian cancer who have been previously treated with 1 to 3 prior systemic treatments.

Gap, Inc. (GPS) 5% LOWER; Citi downgraded from Neutral to Sell with a price target of $8.00 (from $13.00).

The Children's Place (NASDAQ:PLCE) 4% LOWER; Citi downgraded from Neutral to Sell with a price target of $36.00 (from $48.00).

Autodesk (NASDAQ:ADSK) 4% LOWER; Deutsche Bank (ETR:DBKGn) downgraded from Buy to Hold with a price target of $225.00 (from $275.00).

Abercrombie & Fitch (ANF) 3% LOWER; Citi downgraded from Buy to Neutral with a price target of $30.

Kohl's (NYSE:KSS) 3% LOWER; Citi downgraded from Buy to Neutral with a price target of $39.00 (from $55.00).

HP Inc (NYSE:HPQ) 3% LOWER; Citi Downgraded shares to Neutral from Buy with a $38 price target.

Carter's (NYSE:CRI) 3% LOWER; Citi downgraded from Buy to Sell with a price target of $68.00 (from $110.00).

Ocugen, Inc. (NASDAQ:OCGN) 2% HIGHER; The FDA lifted the clinical hold on the Companys Phase 2/3 clinical trial, OCU-002, for COVAXIN (BBV152).

Tesla (NASDAQ:TSLA) 1% LOWER; plans to restore production at its Shanghai plant to the level at which it had operated before the city's COVID-19 lockdown by Tuesday, a day later than its most recent recovery plan, according to an internal memo seen by Reuters.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.